"Advancing obesity and obesity-related trials with patients at the center of development.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESFrom first-in-human to global registration, IQVIA delivers end-to-end hematology expertise to accelerate innovation and improve patient outcomes worldwide.
IQVIA is at the forefront of early-phase innovation in hematology, driving more intelligent and faster development across both malignant and classical conditions. Our teams apply adaptive trial designs, advanced modeling and simulation, and regulatory-aligned dose optimization to reduce risk and accelerate insights.
As part of our commitment to regulatory excellence, we align with FDA’s Project Optimus and Project FrontRunner initiatives, supporting more meaningful outcomes for patients.
From first-in-human studies in acute myeloid leukemia (AML), diffuse large B-cell lymphoma (DLBCL), multiple myeloma, and chronic lymphocytic leukemia (CLL) to complex trials in sickle cell disease and bone marrow failure syndromes, we combine scientific rigor with cutting-edge tools to deliver earlier answers and more efficient development pathways.
Therapeutically aligned solutions to advance your clinical program to the next milestone.
Access new resources for advanced therapy development, from candidate identification through market authorization.
Build on our experience of more than 245 rare disease studies in 96 countries to fulfill your promise of hope to millions around the world.
The right pediatric program to deliver your medicine sooner.
Unravel the complexities of cancer treatment with patient-level data-driven solutions.
